CoChat

Induction of Spermatogenesis by Recombinant Follicle‐Stimulating Hormone (Puregon) in Hypogonadotropic Azoospermic Men Who Failed to Respond to Human Chorionic Gonadotropin Alone

Open access
Bouloux, Pierre‐Marc G., Nieschlag, Eberhard, Burger, Henry G., Skakkebaek, Niels E., Wu, Frederick C.W., Handelsman, David J., Baker, Gordon H.W., Ochsenkuehn, Robert, Syska, Annemarie, McLachlan, Robert I., Giwercman, Aleksander, Conway, Ann J., Turner, Leo, van Kuijk, Jacqueline H.M., Voortman, Gerrit · 2003 · Journal of Andrology
Cited by 107

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

A multicenter, open‐label, randomized efficacy and safety study was performed with combined human chorionic gonadotropin (hCG) and recombinant follicle‐stimulating hormone (recFSH) (Puregon®) treatment to induce spermatogenesis in hypogonadotropic hypogonadal male patients. Patients were pretreated for 16 weeks with hCG to normalize testosterone levels. A total of 30 of 49 (61%) subjects had normalized testosterone levels but were still azoospermic after the hCG‐alone phase. These patients were randomized into 2 treatment schemes with recFSH (2 × 225 IU recFSH per week [group A] or 3 × 150 IU recFSH per week [group B]), in combination with hCG for a period of 48 weeks. Total testosterone increased during the hCG‐alone period from 1.08 and 1.22 ng/mL to 6.26 and 4.52 ng/mL for groups A and B, respectively. Combined gonadotropin treatment was effective in inducing spermatogenesis (sperm count ≥1 × 10 6/mL) in 14 of 30 subjects (47%) and this was achieved after a median duration of treatment of approximately 5.5 months. Treatment time necessary for first sperm cells to appear in the ejaculate was related to the initial testicular volume. Subjects with a history of maldescended testes (11 of 30 subjects, 37%) showed a lower mean response to treatment as indicated by the relatively lower number of subjects reaching levels of at least 1 × 10 6 sperm cells per milliliter. Combined testicular volume increased during combined gonadotropin treatment from 11.4 to 24.0 mL. Although subjects with a history of maldescended testes had a lower starting testicular volume, subjects with and without a history of maldescended testes showed approximately the same relative increase in testicular volume. Total testosterone levels showed only a minor further increase during the combined gonadotropin treatment period. In conclusion, a weekly dose of 450 IU (3 × 150 IU or 2 × 225 IU) recFSH, in addition to hCG, was able to induce spermatogenesis in many hypogonadotropic azoospermic men who failed to respond to treatment with hCG alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1939-4640.2003.tb02712.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 107

Metadata

Authors
Bouloux, P. G., Nieschlag, E., Burger, H. G., Skakkebaek, N. E., Wu, F. C. W., Handelsman, D. J., Baker, G. H. W., Ochsenkuehn, R., Syska, A., McLachlan, R. I., Giwercman, A., Conway, A. J., Turner, L., van Kuijk, J. H. M., & Voortman, G.
Venue
Journal of Andrology
Publisher
Wiley
Published
2003-07-08
Volume
24
Issue
4
Pages
604-611
ISSN
  • 0196-3635 (ISSN-L)
  • 1939-4640
OpenAlex
W1867714673
Cited by
107
References
3
FWCI
1.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Induction of Spermatogenesis by Recombinant Follicle‐Stimulating Hormone (Puregon) in Hypogonadotropic Azoospermic Men Who Failed to Respond to Human Chorionic Gonadotropin Alone. https://app.cochat.ai/papers/10.1002/j.1939-4640.2003.tb02712.x
The paper
Bouloux, P. G., Nieschlag, E., Burger, H. G., Skakkebaek, N. E., Wu, F. C. W., Handelsman, D. J., Baker, G. H. W., Ochsenkuehn, R., Syska, A., McLachlan, R. I., Giwercman, A., Conway, A. J., Turner, L., van Kuijk, J. H. M., & Voortman, G. (2003). Induction of Spermatogenesis by Recombinant Follicle‐Stimulating Hormone (Puregon) in Hypogonadotropic Azoospermic Men Who Failed to Respond to Human Chorionic Gonadotropin Alone. Journal of Andrology. https://doi.org/10.1002/j.1939-4640.2003.tb02712.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.